Company Profile For Biovail Corporation

Biovail Corporation (BVF.TO) (Toronto Stock Exchange)

sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·

As of 2:40am IST

15.00CAD

Price Change

-0.03

Percent Change

-0.20%

Analyst Recommendations

Overview

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, Biovail Corporation's revenues increased 1% to $579.4M. Net income increased 30% to $103.5M. Revenues reflect an increase in sales of the products of the company. Net income also reflects a decrease in restructuring costs, lower legal settlement expenses, a decrease in selling, general & administration expenses, the absence of impairment loss and an increase in operating income.